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Purpose: The conventional outflow pathway provides the primary source of resistance to aqueous humor drainage,
regulating intraocular pressure. Despite large pressure gradients across the inner wall of Schlemm’s canal (SC), cells
remain attached to their basement membrane. The goal of this study was to examine integrin-extracellular matrix binding
partners of the inner wall basement membrane that facilitate attachment.
Methods:  Human  outflow  tissues  and  cultured  cells  were  analyzed  by  immunofluorescence  and  western  blotting,
respectively. Radial sections of human donor eyes or en face preparations of human SC inner wall were probed with
antibodies that specifically recognize collagens (Type I, III, and IV), laminins (LM-332 and LM-511) and laminin-specific
integrin subunits, α3, α6, β1, and β4, typical of vascular endothelia.
Results: Immunofluorescence studies showed collagens Type I and IV in the SC basement membrane but not collagen
III. As expected with mature vascular endothelia, SC cells in situ expressed LM-511 but not LM-332. Significantly, the
integrin α6 subunit was expressed uniquely by SC. En face labeling of the inner wall displayed integrin α6 colocalizing
with LM α5 at the cell periphery. Western blots of cultured human SC endothelial cell monolayers confirmed expression
of Type I collagen, collagen IV, LM-511, and the α6 integrin subunit. Interestingly, LM-332 was present in cultured SC
cells up to 60 days post-confluence.
Conclusions: Even though cells of the inner wall endure pressure gradients in the basal to apical direction, opposite of
other endothelia, human SC cells express basement membrane proteins and their cognate integrins typical of vascular
endothelia.
Elevated intraocular pressure (IOP) is a major risk factor
for  the  development  of  primary  open-angle  glaucoma
(POAG)  [1].  In  POAG,  conventional  outflow  tissue
dysfunction causes increased resistance to aqueous humor
drainage,  resulting  in  elevated  IOP  [2,3].  The  principal
contributor to increased resistance in the conventional outflow
pathway remains unknown; however the location is likely in
the juxtacanalicular region of the trabecular meshwork, near
the inner wall of Schlemm's canal (SC) [3-9].
With its unique architecture and basal to apical direction
of  flow,  Schlemm's  canal  inner  wall  creates  a  dynamic
microenvironment  for  SC  endothelial  cells.  Massive
mechanical loads and a discontinuous basement membrane
suggest  the  necessity  of  strong  cell-matrix  adhesion  in
maintaining a continuous barrier to fluid flow [10,11]. Since
the  strength  of  cellular  adhesion  is  dependent  on  both
structural  extracellular  matrix  (ECM)  and  integrins,  it  is
important to identify and understand their relationship at the
inner wall of Schlemm’s canal.
Mature  vascular  endothelial  basement  membranes
contain  self-assembling  lattices  of  collagen  IV  and
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laminin-511 connected by molecules of perlecan and nidogen
[12]. Additional structural proteins, such as tensile collagen I
and other laminins, are also incorporated into the basal lamina
[13].  The  laminin  expression  profile  of  endothelia  varies
during  development  and  determines  tissue  function  [14].
Endothelial cell integrins also play a large role in maintaining
cell-matrix  adhesion.  Vascular  endothelial  cells  express
integrins α3β1, α6β1, and α6β4 to bind to laminin, while
collagen-specific integrins include α1β1 and α2β1 [15]. Since
SC  inner  wall  endothelia  share  similarities  with  vascular
endothelia,  perhaps  SC  cells  express  a  similar  pattern  of
basement membrane and integrin proteins [16-18].
Previous  attempts  to  identify  extracellular  matrix
proteins and integrins in Schlemm's canal basal lamina have
provided preliminary information [19-25]. However, some
studies used antibodies later shown to be non-specific. For
example,  antibodies  previously  thought  to  identify
laminin-111 also bind laminin-511 and laminin-411. Recent
work  with  collagens  and  laminins  has  resulted  in  well
characterized  and  selective  antibodies  for  cell-matrix
adhesion research.
In the present study, by examining the expression of
integrins,  collagens  and  laminins  in  situ  and  in  vitro,  we
describe the major structural proteins of Schlemm's canal
basal lamina, identify a uniquely expressed integrin subunit
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199by SC cells in the outflow pathway and define variations in
ECM expression caused by in vitro culture models.
METHODS
Human tissue: Post mortem enucleated eyes were obtained
from  National  Disease  Research  Interchange  (NDRI;
Philadelphia, PA), the Life Legacy Foundation (Tucson, AZ)
and Sun Health Research Institute (Sun City, AZ), according
to the guidelines of the Declaration of Helsinki for research
involving human tissue. All tissue used was free of known
ocular disease and maintained in a humid chamber at 4 °C
until dissection.
SC cell culture: Human SC cells were isolated from donor
eyes  using  a  cannulation  technique  developed  in  our
laboratory and cultured as previously described [26]. The cells
were maintained as stable monolayers in Dulbecco’s modified
Eagle’s medium (DMEM, low glucose; Invitrogen, Austin,
TX), supplemented with 10% fetal bovine serum, penicillin
(100  U/ml),  streptomycin  (0.1  mg/ml)  and  glutamine
(0.29 mg/ml; Life Technologies). Cells were used between
passages 2–5 and maintained at confluence for at least one
week before testing. Five different primary cell culture strains
(SC45, SC51, SC53, SC55, and SC56) were isolated from eye
donors (64, 66, 44, 29, and 29 years old, respectively) and
were used in experiments as available.
TM cell culture: Human TM cells were also isolated from
donor eyes, using a blunt dissection technique followed by
extracellular  matrix  digestion  that  was  developed  in  our
laboratory [27]. The cells were brought to and maintained at
a  stable  monolayer  using  Dulbecco’s  modified  Eagle’s
medium (DMEM, low glucose), containing 10% fetal bovine
serum, penicillin (100 U/ml), streptomycin (0.1 mg/ml) and
glutamine (0.29 mg/ml). Upon reaching confluence, the fetal
bovine  serum  concentration  was  reduced  to  1%  and
maintained for at least a week until testing. Four different
primary cell culture strains (TM89, TM90, TM92, and TM93)
were isolated from donor eyes (64 years, 4 months, 38 years,
and 35 years old, respectively) and were used in experiments
as available.
Western blot: Media was removed from confluent monolayers
of  SC  and  TM  cells  and  rinsed  with  ice-cold  phosphate-
buffered  saline  (PBS;  Life  Technologies).  Cells  were
mechanically  scraped  into  ice-cold  radio-
immunoprecipitation assay (RIPA) buffer (Sigma, St. Louis,
MO)  with  protease  inhibitors  (Complete  Mini;  Roche,
Indianapolis, IN), and chilled on ice for 10 min. The samples
were  then  centrifuged  at  20,000×  g  for  8  min  and  the
supernatant removed, tested for total protein (BCA assay;
Pierce, Rockford, IL) and frozen at −80 °C. Lysates were
solubilized in Laemmli buffer or non-reducing buffer and
boiled for 10 min before fractionating proteins (10 μg total
protein/well) on SDS–PAGE gels (4%–15% gradient, 7.5%
or 10% non-gradient). Fractionated proteins were transferred
overnight onto nitrocellulose membranes by electrophoresis
at 21 V. The membranes were blocked with 5% non-fat dry
milk in Tris-buffered saline with 0.2% Tween-20 (TBS-T) and
probed with antibodies for western blot analysis (see Table 1
for a list of antibody conditions). After being rinsed four times
for 10 min in TBS-T, HRP-conjugated secondary antibodies
(Jackson  Immunoresearch,  West  Grove,  PA)  were  added.
Chemiluminescent  substrate  (HyGLO,  Denville  or
ADVANCE;  Pierce)  was  added  to  the  membranes
immediately before exposure to X-ray film (Genesee, San
Diego, CA).
Confocal  immunofluorescence  microscopy:  Radial  wedges
excised  from  the  anterior  segments  of  fresh  human  post
mortem  eyes  were  frozen  in  optimal  cutting  temperature
compound  (OCT;  Sakura,  Torrance,  CA).  The  tissue  was
sectioned (6.5 μm) radially and fixed for 10 min in ice-cold
acetone. The slides were incubated for 30 min in the following
antibodies diluted in PBS: anti-collagen Type I (Biogenesis/
AbD  Serotec,  Raleigh,  NC),  anti-collagen  III  (Biogenesis
TABLE 1. ANTIBODIES USED FOR WESTERN BLOTTING.
Antibody Dilution Clone/catalog Gel conditions
Collagen I 1:5,000 Anti-CN1 LB
Collagen IV 1:1,000 IV-4H122 NRB
Laminin α3 1:1,000 BM1656 LB
Laminin α5 1:1,000 sc-201454 LB
Laminin β3 1:1,000 sc-55834 LB
Laminin γ1 1:500 Clone 175 LB
Laminin γ2 1:1,000 2E83 LB
Integrin α1 1:500 FB123 NRB
Integrin α2 1:1,000 AB19363 LB
Integrin α3/α6 1:10,000 AA6A7 NRB
        1Immunohistochemical research (Gilbertsville, PA). 2Calbiochem (San Diego, CA). 3Millipore (Billerica, MA). 4Santa Cruz
        Biotechnologies (Santa Cruz, CA). 5BD Biosciences (Franklin Lakes, NJ). 6BM165; Dr. Robert Burgeson, Harvard University,
        Cambridge, MA and Dr. Peter Marinkovich, Stanford University, Palo Alto, CA, 7Clone 4C7; Millipore, Billerica, MA. In the
        table, NRB indicates non-reducing buffer and LB indicates Laemmli buffer.
Molecular Vision 2011; 17:199-209 <http://www.molvis.org/molvis/v17/a24> © 2011 Molecular Vision
200Labs and Abcam, Cambridge, MA), anti-collagen IV alpha 1
(Clone  H11;  gift  of  Dr.  Yoshikazu  Sado,  Shigei  Medical
Research  Institute,  Japan),  anti-integrin  alpha  6  (JIB5;
Caroline Damsky, Department of Cell and Tissue Biology,
UC San Francisco, San Francisco, CA), anti-integrin alpha 3
(P1B5; Millipore, Billerica, MA), anti-integrin beta 1 (P4G11,
Chemicon),  anti-integrin  beta  4  (Chemicon),  anti-laminin
alpha 3 (BM165; Dr. Robert Burgeson, Harvard University,
Cambridge,  MA  and  Dr.  Peter  Marinkovich,  Stanford
University,  Palo  Alto,  CA),  anti-laminin  alpha  4  (FC10;
generated by Dr. Artturi Virtanen, University of Helsinki,
Finland), or anti-laminin alpha 5 (Clone 4C7; Millipore). The
slides were then rinsed three times for 5 min in PBS before
incubation with secondary antibodies (Alexa-Fluor 488 goat
anti-mouse, goat anti-rabbit, or goat anti-rat) for 30 min. The
slides were washed once more and then mounted and viewed
with a confocal microscope (Zeiss 7700L, Carl Zeiss, Inc,
Thornwood,  NY).  We  evaluated  background  labeling  and
tissue autofluorescence by incubation of tissue sections with
secondary  antibodies  alone  and  imaging  under  identical
conditions as the experimental samples.
Immunoprecipitation: Confluent monolayers of SC or TM
cells  were  rinsed  in  ice-cold  PBS  and  then  mechanically
scraped  into  ice-cold  RIPA  buffer  and  centrifuged,  as
described before. In parallel, protein G beads (Immunopure;
Pierce)  were  washed  with  RIPA  buffer.  Solubilized  cell
supernatants were pre-cleared with an aliquot of washed beads
for 1 h at 4 °C with rotation. Aliquots of cell supernatants
(100  μg  total  protein)  were  used  for  each
immunoprecipitation. Antibodies (1 μg) were added to each
samples and rotated for 1 h at 4 °C. Upon addition of the beads,
the sample + antibody + bead solution was rotated at 4 °C
overnight.  Antibody  complexes  were  isolated  by
centrifugation  at  6,000×  g  for  1  min.  After  removing
supernatant, the beads were washed three times (500 μl) with
ice-cold RIPA buffer before loading buffer (40 μl) was added
to  the  beads.  After  boiling  at  100  °C  for  10  min  and
centrifugation at 6,000× g for one min, the supernatants were
analyzed by SDS–PAGE and western blotting as described
before.  Reverse  co-immunoprecipitations  for  laminin-511
were  performed  to  determine  whether  laminin  subunits
assembled. The antibody pair used was laminin α5 (sc-20145)
and laminin γ1 (2E8). In addition, immunoprecipitation to
specifically  detect  integrin  α6  in  SC  and  TM  cells  used
integrin α6 antibody (J1B5) as the pull-down antibody and
integrin α3/α6 antibody (AA6A) to probe.
En face labeling: Human eyes were obtained from the Eye
Bank of Canada (Ontario Division, Toronto, Canada) and
stored in moistened chambers at 4 °C before use. To preserve
outflow  structures,  eyes  were  perfused  using  standard
methods [28] and fixed under pressure (8 mmHg) by anterior
chamber exchange with 3% formalin in PBS and perfused for
a further 30 min. They were then removed from the system,
hemisected and the outflow tissue cut into wedges and stored
in 15% glycerol in PBS at −20 °C. Radial segments of the
limbal  area  were  microdissected  using  a  modification  of
previously described techniques [29,30]. Briefly, the TM and
adherent inner wall of SC were carefully folded anteriorly.
This procedure opened SC like a book (with the book spine
analogous to the anterior margin of the canal) allowing en-
face visualization of both the inner and outer wall endothelia.
Tissue was permeabilized in cold acetone for 10 min and
blocked with 10% goat serum (Sigma)/10% donkey serum
(Jackson  Immunoresearch)  in  PBS,  for  30  min  at  room
temperature. The inner wall and underlying TM were labeled
with antibodies to visualize laminin α5, integrin α6, CD31 and
nuclei. Laminin α5 was labeled with rabbit anti-Laminin α5
IgG (Santa Cruz Biotechnology, Santa Cruz, CA) diluted 1:50
in  PBS  and  incubated  overnight  at  4  ⁰C,  followed  by
incubation  in  Alexa-647  goat  anti-rabbit  IgG  (Invitrogen,
Austin, TX) diluted 1:150 for 3 h. Integrin α6 was labeled with
rat anti-Integrin α6 (gift of Damsky Lab) diluted 1:50 in dPBS
and incubated overnight at 4 °C, followed by incubation in
Cy3 goat anti-rat IgG (Abcam, Cambridge, MA) diluted 1:100
in dPBS, for 3 h at RT. CD31 was labeled with mouse anti-
CD31 (DAKO, Glostrup, Denmark) in dPBS and incubated
overnight at 4 °C, followed by incubation in Cy2 donkey anti-
mouse IgG (Jackson Immunoresearch), diluted 1:100, for 3 h
at RT. For negative controls, tissue was treated as above while
excluding  the  primary  antibodies.  Nuclei  were  stained  by
incubation for 5 min at RT in DAPI (Invitrogen, Austin, TX)
diluted at 2 µg/ml in PBS. Samples were examined using a
Zeiss LSM 510 meta confocal microscope (Carl Zeiss Inc.,
Jena, Germany). Images were viewed using Zeiss LSM Image
Browser version 4.2 (Carl Zeiss Inc.).
RESULTS
To  better  understand  the  mechanisms  by  which  cells  of
Schlemm’s canal (SC) inner wall withstand pressure gradients
in the basal to apical direction and remain adherent to their
basement membrane, we examined expression levels of key
matrix and adhesion proteins by Schlemm’s canal endothelia
(vascular endothelial cadherin labeling marks SC; Figure 1A).
We  found  that  a  primary  structural  component  of  the
extracellular  matrix,  type  I  collagen,  was  a  prominent
component of SC inner wall basement membrane in situ as
well  as  in  the  TM  (Figure  1A).  Similarly,  we  observed
collagen  IV,  present  in  all  basement  membranes  in  the
conventional  outflow  pathway,  including  SC’s  inner  wall
(Figure 1A). We were unable to detect type III collagen in
outflow  pathway  tissues,  but  did  see  positive  staining  in
human crystalline lens capsule (data not shown). Both type I
and type IV collagen were produced by mature monolayers of
SC and TM cells in culture. Type I collagen in vitro was
represented  by  multiple  bands  due  to  post-translational
modifications and protein solubility (Figure 1B). While the
production of collagen I was similar between SC and TM cells,
collagen IV production was much greater in TM cells.
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201Laminin-511 is the dominant laminin type expressed by
both SC, including at the inner wall, and TM tissues in situ
(α5;  Figure  2A).  In  contrast,  we  were  unable  to  detect
laminin-332  in  the  conventional  tract  (α3;  Figure  2A).
Positive staining with laminin-332 antibodies was observed
in human prostate tissue (data not shown). We looked at these
two laminins in vitro and confirmed that cultured SC and TM
cell monolayers produced laminin-511 (α5 and β1). To verify
Figure  1.  Collagens  in  human
conventional  outflow  pathway  and
cultured  cells.  A:  Confocal
immunofluorescence  microscopy  of
outflow tissues from cadaveric human
eyes examining the expression levels of
collagen (CN) I, III, and IV. Vascular
endothelial cadherin (VE-cad) labeling
was used as positive control for integrity
of  tissue  antigens  and  localization  of
Schlemm’s  canal  (SC).  Shown  are
representative  images  taken  from
section of one donor eye of 3 examined.
B:  Western  blot  analysis  of  collagen
levels  in  different  strains  of  cultured
human trabecular meshwork (TM) and
SC  cell  monolayers  isolated  from
different  individual  eye  donors.  Anti-
collagen  I  IgGs  recognized  multiple
bands  between  140  and  40  kDa,
corresponding  to  post-translational
modifications.
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202that subunits were being assembled into heterotrimers, co-
immunoprecipitation  assays  were  executed,  pulling  down
protein  complexes  with  antibodies  that  recognize  the  γ1
laminin subunit and probing blots with anti-α5 antibodies
(Figure 2B). Interestingly, we observed that both outflow cell
types  also  produce  laminin-332  (β3;  Figure  2B)  with  SC
producing noticeably more even in cell monolayers confluent
for 8 weeks.
To investigate the integrin pairs, namely α1β1, α2β1,
α3β1, α6β1 and α6β4, that may be mediating adhesion of SC
to its basal lamina, we examined human tissue and cells for
expression  levels  of  individual  integrin  subunits.  The
promiscuous  integrin-β1  and  collagen-specific  integrin-α2
were abundantly expressed by both TM and SC cells in situ
(Figure  3A)  and  in  vitro  (Figure  3B),  respectively.  With
respect to laminin-specific subunits, we found α3, α6, and β4
in  conventional  outflow  pathway  tissues  (Figure  3A  and
Figure 4A). Expression was confirmed for integrin α3/α6 in
cultured cell monolayers, showing similar expression levels
between  SC  and  TM  cells  (Figure  3B).  In  contrast,  we
observed  that  integrin  α6  was  uniquely  expressed  by
Schlemm’s canal in the outflow tract in situ (Figure 4A) and
by  scleral  blood  vessels.  We  confirmed  the  restricted
expression  pattern  of  integrin  α6  in  cultured  SC  cell
monolayers  (Figure  4B),  not  detecting  expression  by  TM
cells.
To examine the relationship between integrin  α6 and
laminin α5, we performed en face confocal imaging of the
inner wall of SC that was probed with antibodies specific for
integrin α6, laminin α5 and CD31. We used the endothelial-
Figure  2.  Laminins-332  and  −511  in
human  conventional  outflow  pathway
and  cultured  cells.  A:  Confocal
immunofluorescence  microscopy  of
endothelial  laminins  (LM)  in  radial
sections  through  human  conventional
outflow  tissues.  Shown  are
representative  images  taken  from  one
human  donor  eye  of  three  that  were
examined. B: western blot analysis of
endothelial laminin levels by different
strains  of  cultured  SC  and  TM  cell
monolayers  isolated  from  different
individual  eye  donors.  Samples  for
laminin α5 blots were obtained after cell
lysates  were  first  immunoprecipitated
with anti-laminin γ1 IgGs.
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203Figure 3. Vascular endothelial integrins
in human conventional outflow pathway
and  cultured  cells.  A:  Confocal
immunofluorescence  microscopy  of
outflow  tissues  from  human,  post-
mortem  eyes  examining  integrin
(INTG)  subunit  levels.  Shown  are
results obtained from one eye from one
individual donor of three total that were
examined. Background fluorescence in
the  absence  of  primary  antibodies  is
shown (2°). B: western blot analysis of
integrin  levels  by  different  human
Schlemm’s  canal  (SC)  and  trabecular
meshwork (TM) cell strains in culture.
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204specific marker, CD31, to locate SC endothelial cells and
simultaneously captured fluorescent signals from the other
two  proteins.  We  observed  that  integrin  α6  displayed  a
perinuclear distribution that extended to cell borders (Figure
Figure 4. Integrin α6 subunit expression
by Schlemm’s canal cells. A: Confocal
immunofluorescence  microscopy  of
outflow  tissues  including  Schlemm’s
canal  (SC)  from  human  donor  eyes
showing  α6  integrin  (INTG)  levels.
Shown is representative image from eye
of individual human donor of 3 donor
eyes  that  were  examined.  For
comparison, a scleral vessel is indicated
(*). B: western blot analysis of different
human  SC  and  trabecular  meshwork
(TM)  cell  strains  checking  for  α6
integrin levels. Cell lysates were first
subjected  to  immunoprecipition  using
integrin α6-specific IgGs, followed by
SDS–PAGE and western blotting using
IgGs  that  recognize  both  α3  and  α6
INTG.
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2055A). Laminin α5 appeared as a distinct pattern of labeling over
the field of view with openings that roughly corresponded to
cell nuclei (Figure 5B). The merged image (Figure 5D) shows
that integrin α6 co-localized with CD31 on the cell surface,
but extended further to the cell periphery, where laminin α5
and integrin α6 appeared to colocalize.
DISCUSSION
In the present study we examined the expression of collagens,
laminins and their cognant integrin receptors, describing the
major structural proteins of human Schlemm's canal (SC)
basal lamina in situ and in cultured human SC monolayers in
vitro.  We  identified  collagen  I,  IV,  and  laminin-511  as
prominent structural proteins in the SC basal lamina plus the
integrin subunits, α2, α3, α6, β1, and β4. Significantly, we
found that α6 was uniquely expressed by SC cells in situ in
the conventional outflow tract and in vitro by cultured SC
cells,  representing  a  novel  cell  marker.  Moreover,  in
colocalization  studies  we  observed  that  laminin-511  and
integrin α6 expression overlapped at the cell periphery of SC,
coincident  with  regions  of  the  inner  wall  displaying  high
adhesive strength in vivo.
Collagens:  With  a  triple  helix  made  of  post-
translationally modified monomers, type I collagen fibrils are
able to extend indefinitely and provide tremendous tensile
strength. Numerous studies have established the presence of
collagen I in ocular tissues, including SC and TM [31]. Our
in situ results are similar to results found previously [19,21,
25,32-37] and are supported for the first time by in vitro data
with cultured human SC cell monolayers. Another collagen in
vascular basal lamina is collagen IV, a basement membrane-
specific lattice collagen [38]. The stability of the collagen IV
lattice provides considerable structural integrity to the basal
lamina and allows the matrix to compensate for mechanical
strain [12]. A previous study found collagen IV in outflow
tissues  by  probing  at  an  ultrastructural  level  [21].  We
Figure 5. En face confocal immunofluorescence microscopy of Schlemm’s canal inner wall. Shown is labeling of the inner wall of SC (viewed
from luminal side) for integrin α6 (A, green), laminin α5 (B, red), CD31 (C, blue). Panel D is a merged image of all three proteins plus nuclei
(brown). Shown is representative image from a human donor eye of 6 total eyes that were examined.
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206confirmed collagen IV expression in situ in the basal lamina
of  Schlemm’s  canal  and  showed  that  SC  cells  produce
collagen IV in vitro, but not to the same extent as TM cells.
The abundant expression of collagen IV by TM cells in culture
may  be  reflective  of  their  role  in  vivo  in  maintaining  an
extensive  network  of  lamellar  beams  in  the  conventional
outflow tract [32,33] or may be a function of cell culture
conditions.
Laminins: Laminin proteins are currently known by the
shorthand “LM” followed by a numeric corresponding to the
alpha, beta, and gamma chains of the heterotrimeric molecule
[39].  For  example,  laminin-5,  also  known  as  kalinin,  is
referred  to  as  laminin-332  and  laminin-10  is  called
laminin-511. Identifying laminin subunits has gotten better
with  more  specific  antibodies.  For  instance,  antibodies
previously thought specific for laminin α1, only expressed in
laminin-111  (LM-1)  and  laminin-121  (LM-3),  have  been
found  to  also  recognize  laminin  α5,  present  in  both
laminin-511 and laminin-521 (LM-11). Antibodies currently
available, including those used in the present study, are more
selective for individual monomers.
Recently, laminin research has undergone a major shift
concerning  the  role  of  laminin  in  the  ECM  and  the
identification of laminin subunits [15,40,41]. As a required
part  of  basement  membranes,  laminins  have  shifted  from
being viewed as structural scaffolding to being hailed as a
determinant in tissue function with various isoforms found to
be  cell  and  tissue  specific.  Moreover,  their  spatial  and
temporal  specificity  has  been  determined  to  affect  tissue
functionality.  For  example,  laminin-332  is  expressed  by
endothelial cells during early development and angiogenesis
[42]. Upon establishing a mature vasculature, the expression
of laminin subunits in vivo shifts to LM-511 [43]. While
integrin-receptor pairs have not been uniquely identified for
every  laminin  heterotrimer,  a  change  from  LM-332  to
LM-511 expression roughly corresponds to integrin subunit
expression shift from integrin α3 to α6 [44]. The observed α6
integrin expression in situ and in vitro by SC suggests that SC
cells in culture have begun to differentiate, preparing for a
LM-511 containing basement membrane.
Our studies support the premise that laminin expression
varies based upon functionality and developmental stage. For
example, we show that laminin-511, but not laminin-332 is
expressed in situ in human outflow tissues. In contrast, we
observed in vitro that both the “immature” (laminin-332) and
“mature” (laminin-511) proteins were produced by cultured
SC and TM cell monolayers. Even though we differentiate
cells in culture for two weeks at confluence, clearly they are
still in an angiogenic state based upon their secretion profile.
As a control, we tested human umbilical vein endothelial cell
monolayers,  and  observed  that  they  also  expressed  both
laminin-332 and laminin-511 at confluence (data not shown).
Integrins: Integrin heterodimers are composed of two
subunits (α and β), connected by covalent bonds. The integrin
heterodimers  connect  the  cell  cytoskeleton  to  the  ECM,
facilitating  signal  transduction  and  affecting  cell  function
[15]. Selectivity of binding to the ECM is dependent upon
combination of the two subunits [45]. For example, while β1
is a widely expressed subunit, it may be involved in laminin
or collagen binding, depending upon the α subunit with which
it  complexes.  For  example  integrin  α1β1  and  α2β1  both
interact  with  collagen  polymers,  while  the  integrin
heterodimers  α3β1  and  α6β1  are  specific  to  laminins.
Interestingly, integrin α6β1 binds selectively to laminin-511
[44]. In the present study, not surprisingly, we found that both
TM and SC cells express the collagen-binding integrin α2 and
laminin-binding integrin, α3. In contrast, SC cells both in situ
and in vitro uniquely expressed integrin α6. We were fortunate
to have a blood vessel present in most of our tissue sections
as  an  internal  positive  control,  confirming  the  known
expression  pattern  of  vascular  endothelial  integrins  (i.e.:
α3β1,  α6β1,  and  α6β4)  [43,46-48].  Our  results  are  in
agreement with the vasculature literature, but different from
another study [24] that did not find integrin β4 in SC, likely
due to differences in available antibodies.
To examine the potential relationship between integrin
α6  (α6β1)  and  laminin-α5  (511)  at  the  level  of  the  SC
basement membrane, we employed en face imaging of the
inner wall of SC from human eyes. This technique allows
simultaneous capture of fluorescent signals from 4 sources
(integrin α6, laminin-α5, CD31 and nuclei) from the luminal
surface of an intact inner wall [29,30]. In our studies we
observed co-localization between laminin α5 and integrin α6
at the periphery of SC cells. These data are consistent with the
idea that this particular integrin-laminin interaction provides
adhesive  support  to  secure  SC  cells  to  their  basement
membrane in opposition to basal to apical flow across the
endothelia. Significantly, the cell periphery, near sites of cell-
cell adhesions are often anchor points for SC cells that have
lifted  off  of  their  basement  membrane,  forming  “giant
vacuoles” in the face of flow. To better understand the role of
integrin-laminin adhesion in giant vacuole formation, it would
be interesting to examine inner wall regions that experience
high flow compared to low flow for differences in localization
and/or expression of integrin-laminin pairs in future studies.
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